I'm fed up': Experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 12, 2014, Pages 1479-1484

  Furin, J ^a   Isaakidis, J P ^b,c   Reid, A J ^c   Kielmann, K ^d  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c Operational Research Unit   (Luxembourg)

^d QUEEN MARGARET UNIVERSITY   (United Kingdom)

Author keywords

Human immunodeficiency virus; India; Multidrug resistant tuberculosis; Operational research; Qualitative study; TBHIV; Treatment adherence

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MALE; MIDDLE AGED; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PERCEPTION; PERSONAL EXPERIENCE; QUALITATIVE ANALYSIS; COST OF ILLNESS; HEALTH CARE DELIVERY; HIV INFECTIONS; HOSPITAL ADMISSION; INTERVIEW; MEDICATION COMPLIANCE; PATIENT; PATIENT SATISFACTION; PREDICTIVE VALUE; PSYCHOLOGY; QUALITATIVE RESEARCH; QUALITY OF LIFE; TIME; TIME TO TREATMENT; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADULT; ANTITUBERCULAR AGENTS; COINFECTION; COST OF ILLNESS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INDIA; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT SATISFACTION; PATIENTS; PERCEPTION; PREDICTIVE VALUE OF TESTS; QUALITATIVE RESEARCH; QUALITY OF LIFE; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; WAITING LISTS;

EID: 84911360441     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Maartens G, Wilkinson R J. Tuberculosis. Lancet 2007; 370: 2030-2043.
2. Mukherjee J S, Rich M L, Socci A R, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004; 363: 474-448.
3. Zignol M, van Gemert W, Falzon D, et al. Surveillance of antituberculosis drug resistance in the world: An updated analysis, 2007-2010. Bull World Health Organ 2012; 90: 111-119D.
4. Ahuja S D, Ashkin D, Avendano M, et al.; the Collaborative Group for Meta-Analysis of Individual Patient Data in MDRTB. Multidrug-resistant pulmonary tuberculosis treatment regimens and patient outcomes: An individual patient data meta-analysis of 9,153 patients. PLOS MED 2012; 9: E1001300.
5. Daley C L, Caminero J A. Management of multidrug resistant tuberculosis. Sem Respir Crit Care Med 2013; 34: 44-59.
6. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348: 119-128.
7. Falzon D, Jaramillo E, Schunemann H J, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
8. Mitnick C D, Appleton S C, Shin S S. Epidemiology and treatment of multidrug resistant tuberculosis. Semin Respir Crit Care Med 29: 499-524.
9. Lu C, Liu Q, Sarma A, Fitzpatrick C, Falzon D, Mitnick C D. A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatment. PLOS ONE 2013; 8: E56074.
10. Boehme C C, Saacks S, O'Brien R J. The changing landscape of diagnostic services for tuberculosis. Sem Respir Crit Care Med 2013; 34: 17-31.
11. Kurbatova E V, Taylor A, Gammino V M, et al. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis 2012; 92: 397-403.
12. Furin J J, BecerraMC, Shin S S, Kim J Y, Bayona J, Farmer P E. Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains. Eur J Clin Microbiol Infect Dis 2000; 19: 132-136.
13. Becerra M C, Appleton S C, Franke M F, et al. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: A retrospective cohort study. Lancet 2011; 377: 147-152.
14. Walter N D, Strong M, Belknap R, Ordway D J, Daley C L, Chan E D. Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis. Respirology 2012; 17: 772-791.
15. Migliori G B, Dheda K, Centis R, et al. Review of multidrugresistant and extensively drug-resistant TB: Global perspectives with a focus on sub-Saharan Africa. Trop Med Int Health 2010; 15: 1052-1066.
16. Bhattacharya S. Early diagnosis of resistant pathogens: How can it improve antimicrobial treatment? Virulence 2013; 4: 172-184.
17. van der Werf M J, Langendam M W, Huitric E, Manissero D. Multidrug resistance after inappropriate tuberculosis treatment: A meta-analysis. Eur Respir J 2012; 39: 1511-1519.
18. Langendam M W, van der Werf M J, Huitric E, Manissero D. Prevalence of inappropriate tuberculosis treatment regimens: A systematic review. Eur Respir J 2012; 39: 1012-1020.
19. Isaakidis P, Cox H S, Varghese B, et al. Ambulatory multidrugresistant tuberculosis treatment outcomes in a cohort of HIVinfected patients in a slum setting in Mumbai, India. Plos ONE 2011; 6: E28066.
20. Isaakidis P, Rangan S, Pradhan A, Ladomirska J, Reid T, Kielmann K. 'I cry every day': Experiences of patients coinfected with HIV and multidrug-resistant tuberculosis. Trop Med Int Health 2013; 18: 1128-1133.
21. Vaismoradi M, Turunen H. Bondas T. Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nurs Health Sci 2013; 15: 398-405.
22. Toczek A, Cox H, du Cros P, Cooke G, Ford N. Strategies for reducing treatment default in drug-resistant tuberculosis: Systematic review and meta-analysis. Int J Tuberc Lung Dis 2013; 17: 299-307.
23. Satti H, McLaughlinMM, Hedt-Gauthier B, et al. Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho. PLOS ONE 2012; 7: E46943.
24. Jonsson G, Furin J, Jennah F, et al. Human rights, mental illness, and HIV: The Luthando Neuropsychiatric HIV Clinic in Soweto, South Africa. Health Hum Rights 2011; 13: 64-72.
25. Weinstein A. Asthma and treatment adherence. Delaware Med J 2000; 72: 209-213.
26. Johnson M, Williams M, Marshall E. Adherent and nonadherent medication- taking in elderly hypertensive patients. Clinical Nursing Research 1999; 8: 318-335.
27. Gler M T, Podewils L J, Munez N, Galipot M, Quelapio M I, Tupasi T E. Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2012; 16: 955-960.
28. Horne R. Patient beliefs about treatment: The hidden determination of treatment outcomes? J Psychosomatic Res 1999; 47: 491-495.
29. Kennedy S, Goggins K, Nollen N. Adherence to HIV medications: The utility of the theory of self-determination. Cogn Ther Res 2004; 28: 611-628.
30. Satti H, McLaughlin M M, Seung K J, Becerra M C, Keshavjee S. High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting. Int J Tuberc Lung Dis 2013; 17: 100-106.
31. Andrews J R, Shah N S, Weissman D, Moll A P, Friedland G, Gandhi N R. Predictors of multidrug- and extensively drugresistant tuberculosis in a high HIV prevalence community. PLOS ONE 2010; 5: E15735.
32. Han L L, Sloutsky A, Canales R, et al. Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens. Int J Tuberc Lung Dis 2005; 9: 818-821.
33. Munro S, Lewin S, Smith H, et al. Patient adherence to TB treatment: A systematic review of qualitative research. PLOS Med 2007; 4: E238.
34. Rachow A, Zumla A, Heinrich N, et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpertw MTB/RIF assay-a clinical validation study. PLOS ONE 2011; 6: E20458.
35. Ebonwu J, Tint K, Ihekweazu C. Low treatment initiation rates among multidrug-resistant tuberculosis patients in Guateng, South Africa, 2011. Int J Tuberc Lung Dis 2013; 17: 1043-1148.